Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 21, 2023

Primary Completion Date

August 8, 2023

Study Completion Date

August 8, 2023

Conditions

CoughHealthy

Interventions

DRUG

Camlipixant

Camlipixant will be administered

DRUG

Rabeprazole

Rabeprazole will be administered

DRUG

Rifampin

Rifampin will be administered.

Trial Locations (1)

GSK Investigational Site, Québec

All Listed Sponsors

lead

Bellus Health Inc. - a GSK company

INDUSTRY